EN
HI
SMS Pharmaceuticals Share price
SMSPHARMA
356.5
0.45 (0.13%)NSE
BSE
Last updated on 20 Aug, 2026 | 15:51 IST
Free Demat with Zero AMC*
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
SMS Pharmaceuticals share price chart
SMS Pharmaceuticals Share Key Metrics
Volume
1.12 L
Market Cap
3338.69 CR
LTQ@LTP
1@356.50
ATP
358.6
Var Margin
22.65 %
Circuit Range
284.85-427.25
Delivery %
65.33 %
Value
4.01 CR
ASM/GSM
No
Market Lot
1
Summary
SMSPHARMA stock price is ₹356.5 as of 21 Aug, 2026. The stock intraday movement has stayed between ₹355.00 and ₹364.15, while SMS Pharmaceuticals share price 52 week high low is ₹221.02 & ₹447.80.
In terms of trading activity, SMSPHARMA share price has recorded a volume of 1,11,900 shares. The SMS Pharmaceuticals has a market cap of ₹93652030. The stock’s Average Traded Price (ATP) stands at ₹358.60, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1 @ ₹356.50.
The SMS Pharmaceuticals upper circuit limit is ₹427.25 & The SMS Pharmaceuticals lower circuit limit is ₹284.85, with a Value of ₹4.01 CR. The Delivery Percentage for the day is 65.33%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
SMS Pharmaceuticals Resistance and Support
Pivot 357.83
Resistance
First Resistance
361.16
Second Resistance
366.28
Third Resistance
369.61
Support
First Support
352.71
Second Support
349.38
Third Support
344.26
SMS Pharmaceuticals Shareholding Pattern
View More- 2016-17
- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Segment
Percent
Total Promoters
68.07%
Mutual Fund
2.81%
Insurance
0%
Foreign Institutional Investors
0.65%
Domestic Institutional Investors
0.02%
Retail
28.45%
Others
0%
Total Promoters
MAR '26
68.07%
JUN '26
68.07%
SMS Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-01 | Quarterly Results |
| 2026-07-31 | Quarterly Results |
| 2026-05-22 | Audited Results & Final Dividend |
| 2026-02-07 | Quarterly Results |
| 2025-11-08 | Quarterly Results |
| 2025-08-09 | Quarterly Results & Others |
| 2025-05-30 | Audited Results & Final Dividend |
| 2025-02-12 | Quarterly Results & Others |
| 2024-11-08 | Quarterly Results |
| 2024-08-05 | Quarterly Results |
| Ex Date | Record Date | |
|---|---|---|
| 2026-09-16 | 2026-09-16 | View More |
SMS Pharmaceuticals News
SMS Pharmaceuticals Ltd - 532815 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
SMS Pharmaceuticals reported Q1 FY27 revenue of Rs.207 crore, marking a 6% YoY increase, and net profit of Rs.20.20 crore, up 8% YoY. The board also approved a Rs.50 crore loan infusion into its subsidiary SMS Peptides Private Limited.
Aug 01 2026 17:04:19
SMS Pharmaceuticals Ltd - 532815 - Announcement Under Regulation 30
SMS Pharmaceuticals Board of Directors approved the Q1 FY27 unaudited financial results. Key resolutions included the re-appointment of Mr. Ramesh Babu Potluri as Chairman and MD for five years and a Rs.50 crore loan to its subsidiary, SMS Peptides Private Limited, both pending shareholder approval. The 38th AGM is set for September 23, 2026, with September 16, 2026, as the record date for the FY26 dividend.
Jul 31 2026 18:05:24
SMS Pharmaceuticals Ltd - 532815 - Fixation Of Record Date
SMS Pharmaceuticals has set September 16, 2026, as the Record Date for determining eligibility for the FY2025-26 dividend. Payment is contingent on shareholder approval at the upcoming Annual General Meeting.
Jul 31 2026 17:35:30
SMS Pharmaceuticals Ltd - 532815 - Announcement under Regulation 30 (LODR)-Change in Management
SMS Pharmaceuticals has re-appointed Mr. Ramesh Babu Potluri as the Chairman and Managing Director for a new term of 5 years, effective from October 1, 2026, until September 30, 2031. This re-appointment is subject to the approval of the company's shareholders at the upcoming general meeting.
Jul 31 2026 17:31:28
SMS Pharmaceuticals Ltd - 532815 - Board Meeting Outcome for Outcome Of Board Meeting And Financial Results
SMS Pharmaceuticals board approved Q1 FY27 cons. financial results, with revenue of ₹206.96 cr (up 5.57% YoY) and net profit of ₹20.20 cr (up 7.94% YoY). The board also re-appointed Mr. Ramesh Babu Potluri as Chairman & MD for a five-year term and sanctioned a ₹50 cr loan to subsidiary SMS Peptides Private Limited for business.
Jul 31 2026 17:13:18
SMS Pharmaceuticals Ltd - 532815 - Update on board meeting
SMS Pharmaceuticals rescheduled its Board meeting to July 31, 2026, to consider Q1 FY27 unaudited financial results. The meeting was originally set for August 1, 2026.
Jul 29 2026 12:25:08
SMS Pharmaceuticals Ltd - 532815 - Board Meeting Intimation for Approval Of Financial Results For The Quarter Ended 30Th June, 2026
SMS Pharmaceuticals' Board is scheduled to meet on August 1, 2026. The primary agenda is to consider and approve the unaudited standalone and consolidated financial results for the first quarter ending June 30, 2026.
Jul 25 2026 15:39:13
Read More
SMS Pharmaceuticals Management
| Name | Position |
|---|---|
| Thirumalesh Tumma | Company Secretary & Compliance Officer |
| Ramesh Babu Potluri | Chairman & Managing Director |
SMS Pharmaceuticals Similar Stocks
Aarti Drugs Ltd.
414.75
6.30 (1.54%)
Unichem Laboratories Ltd.
516.55
3.65 (0.71%)
Indraprastha Medical Corporation Ltd.
376.80
2.35 (0.63%)
Kwality Pharmaceuticals Ltd.
3630.30
177.90 (5.15%)
Advanced Enzyme Technologies Ltd.
303.00
-2.20 (0.72%)
Ind-Swift Laboratories Ltd.
333.51
11.45 (3.56%)
Hikal Ltd.
212.26
-1.85 (0.86%)
Dishman Carbogen Amcis Ltd.
172.41
0.01 (0.01%)
Solara Active Pharma Sciences Ltd.
640.00
89.95 (16.35%)
Beta Drugs Ltd.
2295.00
-104.20 (4.34%)
SMS Pharmaceuticals FAQs
The Buying Price of SMS Pharmaceuticals share is 356.5 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy SMS Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for SMS Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of SMS Pharmaceuticals shares is 32.58. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio SMS Pharmaceuticals shares is 4.14. Useful to assess the stock's value relative to its book value.
To assess SMS Pharmaceuticals’s valuation compare Sector P/E, P/B which are 65.06 & 3.33 with sector averages, along with growth rates and financial metrics.
The Market Cap of SMS Pharmaceuticals is 3338.69 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of SMS Pharmaceuticals share price is 447.80 & 221.02. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
SMS Pharmaceuticals belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in SMSPHARMA
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC